The Leogane, Haiti demonstration project: Decreased microfilaremia and program costs after three years of mass drug administration

American Journal of Tropical Medicine and Hygiene

Volumn 73, Issue 5, 2005, Pages 888-894

  De Rochars, Madsen Beau ^b   Kanjilal, Sanjat ^c   Direny, Abdel N ^b   Radday, Jeanne ^a   Lafontant, Jack G ^b   Mathieu, Els ^a   Rheingans, Richard D ^c   Haddix, Anne C ^c   Streit, Thomas G ^d   Beach, Michael J ^a   Addiss, David G ^a   Lammie, Patrick J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Hôpital Ste Croix ^*  (Haïti)

^c EMORY UNIVERSITY   (United States)

^d UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; DIETHYLCARBAMAZINE;

ARTICLE; COST BENEFIT ANALYSIS; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; EDUCATION PROGRAM; ENDEMIC DISEASE; FEVER; HAITI; HEADACHE; HEALTH CENTER; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MICROFILARIASIS; PAIN; PREVALENCE; SCHOOL; SCROTUM; STATISTICAL ANALYSIS; VOLUNTEER; WUCHERERIA BANCROFTI;

WUCHERERIA BANCROFTI;

EID: 28044462455     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2005.73.888     Document Type: Article

References (20)

1. Molyneux DH, Zagaria N, 2002. Lymphatic filariasis elimination: progress in global programme development. Ann Trop Med Parasitol 96: S15-S40.
2. Ottesen EA, Duke BOL, Karam M, Behbenani K, 1997. Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ 75: 491-503.
3. Cao WC, Xu JF, Ren ZX, 1994. Epidemiological surveillance of filariasis after its control in Shandong Province, China. Southeast Asian J Trop Med Public Health 25: 714-7183
4. Webber RH, 1979. Eradication of Wuchereria bancrofti infection through vector control. Trans R Soc Trop Med Hyg 73: 722-724.
5. Rawlins SC, Siung-Chang A, Baboolal S, Chadee DD, 2004. Evidence for the interruption of transmission of lymphatic filariasis among schoolchildren in Trinidad and Tobago. Trans R Soc Trop Med Hyg 98: 473-477.
6. Chernin E, 1987. the disappearance of Bancroftian filariasis from Charleston, South Carolina. Am J Trop Med Hyg 37: 111-114.
7. Weil GJ, Lammie PJ, Weiss N, 1997. The ICT filariasis test: A rapid format antigen test for diagnosis of Bancroftian filariasis. Parasitol Today 13: 401-404.
8. Brown KR, Ricci FM, Ottesen EA, 2000. Ivermectin: effectiveness in lymphatic filariasis. Parasitology 121(Suppl): S133-S146.
9. Ottesen EA, Ismail MM, Horton J, 1999. The role of albendazole in programs to eliminate lymphatic filariasis. Parasitol Today 15: 382-386.
10. Bockarie MJ, Tisch DJ, Kastens W, Alexander ND, Dimber Z, Bockarie F, Ibam E, Alpers MP, Kazura JW, 2002. Mass treatment to eliminate filariasis in Papua New Guinea. N Engl J Med 347: 1841-1848.
11. Boyd HA, Waller LA, Flanders WD, Beach MJ, Sivilus JS, Lovince R, Lammie PJ, Addiss DG, 2004. Community- and individual-level determinants of Wuchereria bancrofti infection in Leogane Commune, Haiti. Am J Trop Med Hyg 70: 266-272.
12. McLaughlin SI, Radday J, Michel MC, Addiss DG, Beach MJ, Lammie PJ, Lammie J, Rheingans R, Lafontant J, 2003. Frequency, severity and costs of adverse reactions following mass treatment for lymphatic filariasis using diethylcarbamazine and albendazole. Leogane, Haiti, 2000. Am J Trop Med Hyg 68: 568-573.
13. Mathieu E, Deming M, Lammie P, McLaughlin S, Beach M, Deodat DJ, Addiss D, 2003. Comparison of methods for estimating drug coverage for filariasis elimination, Leogane, Haiti. Trans R Soc Trop Med Hyg 97: 501-505.
14. Mathieu E, Lammie PJ, Radday J, Montilus W, Beach MJ, Streit T, Wendt J, Addiss DG, 2004. What influenced people to participate in a mass treatment campaign against lymphatic filariasis? Ann Trop Med Parasitol 98: 703-714.
15. Beau de Rochars M, Direny AN, Roberts JM, Addiss DG, Radday J, Beach MJ, Streit TG, Dardith D, Lafontant J, Lammie PJ, 2004. Community-wide reduction in prevalence and intensity of intestinal helminths as a collateral benefit of lymphatic filariasis elimination programs. Am J Trop Med Hyg 71: 466-470.
16. Stolk W, Swaminathan S, van Oortmarssen GJ, Das PK, Habbema JD, 2003. Prospects for elimination of Bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study. J Infect Dis 188: 1371-1381.
17. Washington CH, Radday J, Streit TG, Boyd HA, Beach MJ, Addiss DG, Lovince R, Lovegrove M, Lafontant JG, Lammie PJ, Hightower AW, 2004. Spatial clustering of filarial transmission before and after a mass drug administration in a setting of low infection prevalence. Filaria J 3: 3.
18. WHO, 2000. Preparing and Implementing a National Plan to Eliminate Lymphatic Gilariasis, Geneva: World Health Organization.
19. Krishnamoorthy K, Ramu K, Srividya A, Appavoo NC, Saxena NB, Lal S, Das PK, 2000. Cost of mass annual single dose diethylcarbamazine distribution for the large scale control of lymphatic filariasis. Ind J Med Res III: 81-89.
20. Michael E, Meyrowitsch DW, Simonsen PE, 1996. Cost and cost effectiveness of mass diethylcarbamazine chemotherapy for the control of Bancroftian filariasis: comparison of four strategies in Tanzania. Trop Med Int Health I: 414-426.